FGF9 is identified as an important epithelial-to-mesenchymal transition signal required for embryo development [36], furthermore, it has been reported to be expressed in various tumors, such as colon cancer, gastric carcinoma and lung carcinoma [37–39]. The gene discussed is FGF9; the disease is lung carcinoma.